The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Pamala A. Jacobson

Department of Experimental and Clinical Pharmacology

College of Pharmacy

University of Minnesota

Minneapolis

USA

[email]@umn.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, USA. 2003 - 2012

References

  1. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. Jacobson, P.A., Schladt, D., Israni, A., Oetting, W.S., Lin, Y.C., Leduc, R., Guan, W., Lamba, V., Matas, A.J. Transplantation (2012) [Pubmed]
  2. Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation. Jacobson, P.A., Schladt, D., Oetting, W.S., Leduc, R., Guan, W., Matas, A.J., Lamba, V., Mannon, R.B., Julian, B.A., Israni, A. Transplantation (2011) [Pubmed]
  3. Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation. Long-Boyle, J., Huang, J., Rydholm, N., Smith, A., Orchard, P., Tolar, J., Jacobson, P. J. Clin. Pharmacol (2011) [Pubmed]
  4. Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. Jacobson, P.A., Oetting, W.S., Brearley, A.M., Leduc, R., Guan, W., Schladt, D., Matas, A.J., Lamba, V., Julian, B.A., Mannon, R.B., Israni, A. Transplantation (2011) [Pubmed]
  5. Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. Jacobson, P.A., Huang, J., Wu, J., Kim, M., Logan, B., Alousi, A., Grimley, M., Bolaños-Meade, J., Ho, V., Levine, J.E., Weisdorf, D. Biol. Blood Marrow Transplant. (2010) [Pubmed]
  6. Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation. Jacobson, P., El-Massah, S.F., Rogosheske, J., Kerr, A., Long-Boyle, J., DeFor, T., Jennissen, C., Brunstein, C., Wagner, J., Tomblyn, M., Weisdorf, D. Bone Marrow Transplant. (2009) [Pubmed]
  7. Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT). Jacobson, P., Huang, J., Rydholm, N., Tran, M., Defor, T., Tolar, J., Orchard, P.J. J. Clin. Pharmacol (2008) [Pubmed]
  8. Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation. Jacobson, P., Rogosheske, J., Barker, J.N., Green, K., Ng, J., Weisdorf, D., Tan, Y., Long, J., Remmel, R., Sawchuk, R., McGlave, P. Clin. Pharmacol. Ther. (2005) [Pubmed]
  9. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation. Jacobson, P.A., Ng, J., Green, K.G., Rogosheske, J., Brundage, R. Biol. Blood Marrow Transplant. (2003) [Pubmed]
 
WikiGenes - Universities